Jacob Mathew, PharmD, MBA

Associate Vice President
Sun Pharmaceutical Industries, Inc.

Poster(s):

• (98) Real-world treatment patterns in patients with psoriasis receiving tildrakizumab compared to ustekinumab
  Wednesday, October 29, 2025